|
Volumn 17, Issue 4, 2001, Pages 1-6
|
Montelukast: Oral alternative to inhaled therapy for persistent asthma
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BAMBUTEROL;
BECLOMETASONE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
DIGOXIN;
FEXOFENADINE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
NEDOCROMIL;
ORAL CONTRACEPTIVE AGENT;
PEPTIDOLEUKOTRIENE;
PLACEBO;
PRANLUKAST;
PREDNISOLONE;
PREDNISONE;
SALMETEROL;
TERFENADINE;
THEOPHYLLINE;
WARFARIN;
ZAFIRLUKAST;
ADULT;
ARTICLE;
ASTHMA;
CHILD;
CHURG STRAUSS SYNDROME;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HUMAN;
LUNG FUNCTION;
PATIENT COMPLIANCE;
SYMPTOM;
|
EID: 0035952177
PISSN: 11720360
EISSN: None
Source Type: Journal
DOI: 10.2165/00042310-200117040-00001 Document Type: Article |
Times cited : (1)
|
References (4)
|